Why the study?
What are the rates and predictors of evidence-based drug prescribing for secondary prevention of acute coronary syndrome in Aboriginal and non-Aboriginal patients in Western Australia?
Population
1,717 patients discharged alive from Western Australian hospitals with a principal diagnosis of acute…
Design
Cross-sectional
Authors
Loading...
Suboptimal ACS discharge prescribing signals need for quality improvement; leaves open causes of higher zero-prescription rates among Aboriginal patients.
What are the rates and predictors of evidence-based drug prescribing for secondary prevention of acute coronary syndrome in Aboriginal and non-Aboriginal patients in Western Australia?
While overall evidence-based prescribing for ACS at discharge was 71% with no difference between Aboriginal and non-Aboriginal patients, disparities exist with Aboriginal patients more likely to receive no secondary prevention medications.
Gausia et al. (2014) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: